CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 160 filers reported holding CONMED CORP in Q4 2017. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,361 | -27.0% | 182,063 | -1.7% | 0.07% | -20.7% |
Q2 2023 | $25,166 | -26.6% | 185,193 | -43.9% | 0.09% | -29.8% |
Q1 2023 | $34,307 | +18.6% | 330,326 | +1.3% | 0.12% | +19.2% |
Q4 2022 | $28,915 | -99.9% | 326,209 | -0.4% | 0.10% | +8.3% |
Q3 2022 | $26,266,000 | -15.8% | 327,624 | +0.5% | 0.10% | -12.7% |
Q2 2022 | $31,213,000 | -16.6% | 325,944 | +29.3% | 0.11% | +10.0% |
Q1 2022 | $37,445,000 | +532.4% | 252,072 | +211.6% | 0.10% | +488.2% |
Q2 2018 | $5,921,000 | -60.8% | 80,891 | -66.1% | 0.02% | -62.2% |
Q1 2018 | $15,103,000 | +10.1% | 238,474 | -11.4% | 0.04% | +15.4% |
Q4 2017 | $13,723,000 | -3.3% | 269,230 | -0.4% | 0.04% | -4.9% |
Q3 2017 | $14,189,000 | +3.0% | 270,430 | 0.0% | 0.04% | 0.0% |
Q2 2017 | $13,776,000 | -5.2% | 270,430 | -17.4% | 0.04% | -6.8% |
Q1 2017 | $14,537,000 | -27.1% | 327,330 | -27.5% | 0.04% | -27.9% |
Q4 2016 | $19,948,000 | +10.3% | 451,630 | 0.0% | 0.06% | +10.9% |
Q3 2016 | $18,092,000 | -17.8% | 451,630 | -2.1% | 0.06% | -20.3% |
Q2 2016 | $22,015,000 | – | 461,230 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |